Article Details

Genmab swallows Merus in US$8bn deal - European Biotechnology Magazine

Retrieved on: 2025-09-30 00:17:31

Tags for this article:

Click the tags to see associated articles and topics

Genmab swallows Merus in US$8bn deal - European Biotechnology Magazine. View article details on hiswai:

Excerpt

... antibodies: while overall response rates were roughly similar, 79% of ... monoclonal antibodies have emerged as the dominant class in the ...

Article found on: european-biotechnology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo